MedPath

The effect of memantine on the pain relief after orthopedic surgery

Phase 2
Conditions
Acute pain.
Acute pain
Registration Number
IRCT2017062413364N4
Lead Sponsor
Vice Chancellor for Research and Technology of Shahid Beheshti University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
180
Inclusion Criteria

patients undergoing elective orthopedic surgery of the lower limbs (calf fracture); aged 18-65 years;physical health status of ASA 1 or 2
Exclusion criteria:ASA physical health status of 3 or 4; diseases of the respiratory system, heart, brain and endocrine glands;any opioid consumption in one week prior to surgery;sensitivity to opioid used in the study;a history of mental illness;MAOIs or SSRIs consumption during 4 weeks before the surgery; pregnancy;history of stroke;type 1 and 2 diabetes mellitus.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: 6, 12, 24, 36 and 48 hours after the surgery. Method of measurement: visual analog score.
Secondary Outcome Measures
NameTimeMethod
Sedation scores. Timepoint: 6, 12, 24, 36 and 48 hours after the surgery. Method of measurement: 0 for restless, 1 for quiet, 2 for sleepy, 3 for confused but with respond to verbal commands, 4 for no response to verbal commands, and 5 for no response to painful stimulus.;Nausea and vomiting. Timepoint: 6, 12, 24, 36 and 48 hours after the surgery. Method of measurement: 1 for mild nausea without the need for medication, 2 for nausea needing medication, 3 for nausea and lack of response to anti-nausea drugs.;Patient satisfaction. Timepoint: At the end of 48 hours post operation. Method of measurement: 0 for absolutely no pain, 1 for sometimes moderate pain, 2 for always moderate pain, 3 for sometimes severe pain, 4 for always moderate pain and sometimes severe pain, and 5 for always severe pain.
© Copyright 2025. All Rights Reserved by MedPath